Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04688658
Title Duvelisib in Combination With Nivolumab in Patients With Advanced Unresectable Melanoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors John Kirkwood
Indications

melanoma

Therapies

Duvelisib + Nivolumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.